Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMC3 pseudogene 1 (SMC3P1) is a retrotransposed homologous pseudogene located at the 2q11.2 locus, likely derived from the final five exons of the SMC3 gene. While SMC3 encodes a critical subunit of the cohesin complex involved in vital cellular processes like sister chromatid cohesion, chromosome segregation, and DNA repair, SMC3P1 does not encode a functional protein and lacks known biological functions. As a non-functional genomic element resulting from retrotransposition, SMC3P1 typically lacks therapeutic relevance, is not considered a biological target, and has no known drug interactions or disease associations. The main molecule of interest for biological functions and disease roles (e.g., Cornelia de Lange syndrome) is SMC3, not SMC3P1. Misidentification or confusion between SMC3 and SMC3P1 is possible, but SMC3P1 is not a valid molecular target. Therefore, any query identifying SMC3 pseudogene 1 as a molecular target is incorrect, as it refers to a pseudogene and not a bona fide therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMC3 pseudogene 1 (SMC3P1).